Pete is CardioLife’s Founder and Chief Scientific Officer, bringing more than 30 years of LVAD development experience from prior roles at Ventracor and Cochlear. He led the original VentrAssist programme through 420+ human implantations, and EasyHeart is built directly on his foundational IP.

Dr Attawar is Chair of Cardiac Surgery and Thoracic Organ Transplants at KIMS Hospital Group, and serves as CardioLife’s Clinical Lead and lead implanting surgeon for EasyHeart’s first-in-human trials. His role anchors the clinical pathway in India and provides direct access to CardioLife’s primary trial and commercialisation venue.

Scott is CardioLife’s CEO, with 20+ years building and scaling organisations across Asia and Australia. His background spans cross-border capital raising, healthcare and impact sectors, with specific expertise in governance, investor relations and structured capital mandates.

Susan is CardioLife’s CFO, bringing 20+ years of finance leadership across multinational manufacturing, supply chain and FP&A. She has led major restructuring programmes delivering product cost reductions — directly relevant to CardioLife’s cost-led global device strategy.